Inhibiting the Type 2 Inflammatory Pathway with Dupilumab is Associated with an Increase in IL ‐4 and IL‐18 Production
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Jymirah Morris,
Tolani F. Olonisakin,
John A. Moore,
BaDoi Phan,
Dana M. Parker,
Bliss A. Uribe,
Stephanie J. Barel,
Eve M.R. Bowers,
Kathleen M. Buchheit,
Tanya M. Laidlaw,
Stella E. Lee Tags: RESEARCH NOTE Source Type: research
More News: Allergy | Allergy & Immunology